Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.

Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas. J Neurooncol. 2003 Feb; 61(3):187-96.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.